CANCER BUZZ PODCAST

CANCER BUZZ spoke to Allison Applebaum, PhD, Psychologist, Memorial Sloan Kettering Cancer Center. Listen as Dr. Applebaum discusses the programs and practices in place at Memorial Sloan Kettering Cancer Center to support caregivers.

At Duke Cancer Institute, the implementation of electronic-consults for patients experiencing endocrine irAEs improved patient access and reduced healthcare utilization.

Listen as we discuss nursing’s role in the care of patients with small cell lung cancer (SCLC).

For several years, this healthcare system struggled to find a sustainable program to perform outreach to patients with outstanding orders for lung, breast, and colon cancer screenings.

Learn how the creation of the first APRT role in the United States established a new model of inpatient care, elevating the radiation therapy skill set and allowing for intervention at key points along the radiation oncology care pathway.

Learn how the creation of the first APRT role in the United States established a new model of inpatient care, elevating the radiation therapy skill set and allowing for intervention at key points along the radiation oncology care pathway.

In this episode, hear about the fully remote TRACK (Target Rare Cancer Knowledge) clinical trial and its unique approach to providing access to biomarker testing for patients in community care settings by leveraging technology.

CANCER BUZZ speaks with Susan Spinosa, president and patient founder of NTRKers, an organization created to support patients with NTRK fusion-positive cancer, about her care journey and the importance of testing for NTRK gene fusions.

CANCER BUZZ speaks with Melissa Kah Poh Loh, MBBCh, BAO, assistant professor of Geriatric Hematology and Oncology about strategies to optimize critical conversations with patients with acute myeloid leukemia.

In this episode, CANCER BUZZ speaks about strategies to address these disparities and optimize care and treatment options for patients with acute myeloid leukemia who do not receive a transplant.

Mary B. Battaglia has been practicing clinical hypnosis for 10 years, working with clients to address issues like anxiety and stress and supported people with different medical issues, including brain, breast, lung, prostate, and skin cancers.

In this episode, CANCER BUZZ speaks about strategies to address these disparities and optimize care and treatment options for patients with acute myeloid leukemia who do not receive a transplant.

This multi-cohort, prospective, nationwide registry study will enroll newly diagnosed oligometastatic HER2+ breast cancer patients.

As biomarker testing can play a critical role in the diagnosis of rare cancers, such as NTRK gene fusion-positive cancers, hear what care teams need to know about identifying patients who may be eligible for this testing.

Breaking down the social stigma that is often still associated with seeking mental health services is key to making cancer care clinicians and staff feel a "sense of safety" and that they will not be penalized for accessing mental health services.

In 2022, ACCC conducted a survey to measure patient, caregiver, and provider perceptions and adoption of messaging tools, electronic questionnaires, and connected devices used to track and monitor symptoms during cancer treatment.

As myeloproliferative neoplasms (MPNs) carry a heavy symptom burden which can significantly impact a patient’s quality of life, hear how multidisciplinary care and psycho-social support can help alleviate this burden for patients.

The goal of treatment for most patients with myelofibrosis is to relieve symptoms. Hear Dr. Gerds discuss standard of care treatment options and new therapies for treating patients with myelofibrosis.

Each year, ACCC is active at the state and federal level, advocating on behalf of its members. In this episode, learn what four core areas ACCC members identified as needing added support.

Tune-in as Dr. Hobbs discusses symptom scoring, risk stratification, and effective practices in building a strong myelofibrosis program.

Listen as Cindy Varga, MD, discusses the positives and negatives with subcutaneous versus intravenous drugs in treating patients with multiple myeloma.